In meningiomas, higher Ki-67 expression levels were linked to poor overall survival (HR = 1.565; 95% confidence interval [CI] = 1.217-2.013) and D/P/RFS (HR = 2.644; 95% CI = 2.264-3.087). This evidence concerns the gene MKI67 and meningioma.